Co-founder and Director
Mr. Hoffmann is entirely dedicated to Network Immunology's systems approach to optimizing and protecting health by way of immuno-therapy. He co-founded Network Immunology in 2003 with Chief Scientist, Dr. Geoffrey Hoffmann.
In 2007, George was appointed Manager of Business Development. In 2009, at a critical point in the Company’s history, he was appointed President and CEO.
Since then, with George has been a major part of driving the Company's success. With the help of an outstanding team, George has led Network Immunology
from a seed stage start-up, to an enterprise with strong data for its platform technology, that is poised for tremendous development and commercialization.
As the communications hub of the company, George has been working with Management, the Directors, and the Scientific Advisory Board, to move the Company’s
novel immuno-therapeutic treatment forward. George ensures that the Company continues to take steps towards negotiating commercial licensing agreements
with large health-focused companies that will provide robust capital gains for shareholders, and further develop Network Immunology’s leading edge